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Prospective Experimental study in which we created a bony defect in the mastoids of rats and filled 
it up with hydroxyapatite to evaluate bone regeneration, to solve the problems of open cavities after 
mastoidectomies that frequently present with otorrhea, infection, granulation tissue and hearing loss.
Objective: The aim was to evaluate bone regeneration in defects created in the mastoids of rats, 
using hydroxyapatite, to see how much of the cavity we could reduce.
Material and methods: Twelve rats Wistar-Furth were used. A 0.5 x 0.5 cm bone defect was created 
in both temporal bones of the rats, and filled with 15 micrograms of hydroxyapatite. The left side 
was used as control. The animals were slaughtered 40 days afterwards and histology analyses were 
carried out.
Results: In the hydroxyapatite group, the new bone growth involved an area of 68.53% of the total; 
and in the control group it was only of 15.97%.
Discussion and Conclusion: It was observed a very good hydroxyapatite integration to the 
temporal bone in this experimental model. The microscopic results were superior with the use of 
hydroxyapatite when compared to the control group. It is a safe method and easy to apply to solve 
the problems of open cavities with chronic discharge and difficult to clean.
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INTRODUCTION
Numerous biomaterials with the capacity to rege-
nerate bone are being tested, materials such as calcium 
hydroxyapatite and tricalcium phosphate1. All these syn-
thetic porous substitutes share advantages when compared 
to auto and allografts, including their easy sterilization and 
storage, let alone their unlimited availability. Among their 
disadvantages, we list: fragile handling, different degrees 
of resorption, poor performance in diaphysis defects and 
potential adverse effects on bone remodelling2. Regarding 
autologous bone grafts, disadvantages include limited 
quantity, inadequate resorption and high morbidity on 
donor site, thus the constant investment in bone graft 
technology3.
Synthetic calcium hydroxyapatite (SCH), [CaIO(PO
4
)
(OH)], is an inorganic material used in bone gaps and a 
component of the mineral phase of calcified tissues. Its 
synthetic equivalent has biocompatibility and osteocon-
duction, which place it among the most important bone 
substitutes available today. It can be used in bone defects 
without load or in gaps in which load, torsional or shea-
ring stress are neutralized by stiff implants, such as plates 
and screws.
Bone regeneration brought about by SCH has been 
studied in different animal and human models. Its first use 
in animal models was in canine proximal tibia defects, 
where the researchers noticed a fast graft take after the 
implant, no adverse effects and high bone regeneration4.
Bone conduction happens when a porous structure 
is implanted on the bone or near it. Fibrovascular tissues, 
capillaries and bone-forming cells migrate to the porous 
structure and start forming new bone. The success of 
such mineral grafts is based on their resorption by osteo-
clasts, which contribute to forming new bone. The non-
decalcified bone graft is gradually and slowly absorbed 
by osteoclasts, which open gaps in the calcified bone, 
enabling vascular growth and the inflow of inflammatory 
cells, which explains how this tissue can maintain its 
mechanical force5.
Moreover, the collagen present in these bone 
substitutes make up the substrate for mineralization and 
promotes osteoinduction. The properties to adsorb mo-
lecules are also clear, promoting an excellent support 
for the longstanding action of anti-cancer drugs in tumor 
processes, such as osteosarcomas6.
There are contraindications for the use of this type 
of material in intraarticular fractures, in which one uses 
autologous grafts because of their adhesiveness capacity. 
Nonetheless, it has been successfully used in osteochondral 
defects in femoral condyles of rabbits7.
Based on all these principles, we started to try to 
use it in the temporal bone, because since it has respira-
tory mucosa areas, it behaves very differently from other 
bones. Our main focus was turned to the mastoid portion 
of the temporal bone, because it is the one most involved 
in chronic otitis, especially cholesteatomas.
Cholesteatomas can be defined as the presence of 
skin in the middle ear cavity and mastoid - places where 
usually there is only respiratory mucosa, thus not sites 
which are ready to bear keratinized epithelium, from the 
ventilation standpoint8.
It has an external matrix made up of keratinized 
stratified squamous epithelium on a fibro-connective 
tissue, which sheds itself in lamellae within the space it 
outlines, filling out and promoting local distension and 
bone erosion.
Cholesteatomas are traditionally classified into con-
genital or acquired, and they can be primary or secondary.
Clinically, the congenital cholesteatoma grows 
insidiously, manifesting itself as progressive conductive 
hearing loss. Meanwhile, acquired cholesteatomas are as-
sociated with migration to the middle ear, attic retraction in 
the primary or tympanic perforation in the secondary, and 
the pathogenesis of the acquired cholesteatoma is directly 
associated with middle ear diseases. The treatment for such 
disorder is primarily surgical, and its basic goals are: to 
eradicate the disease, to dry the middle ear and hearing 
conservation. Surgery is tympanomastoidectomy, which 
creates a cavity that is often times large, without proper 
ventilation through the external ear canal, and causes 
some problems such as hearing loss, otorrhea and the very 
discomfort of not being able to wet one’s ear. This cavity 
is epithelized in the months that follow the surgery, and 
there is more skin forming on top of the bone throughout 
the cavity. The larger the cavity, the larger must be the 
meatoplasty, because if the skin surface is enlarged, the 
ventilation on this skin must also be greater, so as to avoid 
forming granulation tissue, secretion and consequently, 
otorrhea. Therefore, two solutions have been tried, one 
would be to increase ventilation, with increasingly larger 
and less esthetic meatuses, or surface reduction, in other 
words, the same size of the cavity, so as to have less epi-
thelial tissue formed coating the cavity9.
OBJECTIVES
The goals of the present study were:
1. to assess the degree of bone regeneration in a 
defect created on the mastoid of rats using synthetic cal-
cium hydroxyapatite, establishing which percentage of the 
mastoid cavity can be reduced, by means of histological 
analysis under light microscopy;
2. to analyze whether or not there is new bone 
formation induction caused by synthetic calcium hydro-
xyapatite.
MATERIALS AND METHODS
In carrying out this study we complied with all the 
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guidelines from the Brazilian College of Experimentation 
with Animals (COBEA). The research project was approved 
by the Ethics in Research with Animals from the Health 
Sciences Sector of the institution under registration # 
AN.016.007.08.11, on December 10, 2008.
Animals used
We used 12 Wistar-Furth adult rats, weighing be-
tween 180-220 grams. They were kept in a proper envi-
ronment, with natural lighting and temperature, and fed 
with ad libitum water and food.
Animal anesthesia
The animals were anesthetized through intramus-
cular injection, for which we used Ketamine 40 mg/kg, 
Diazepam 2 mg/kg and Butorphanol 2 mg/kg, and the 
doses were repeated during the procedure, according to 
the need, then the retroauricular access was used (Figure 
1) for exposure of the external ear canal and the mastoid 
(Figure 2).
Bone defect creation
A 0.5cm x 0.5cm bone defect on the mastoid was 
created on all the animals with a round # 7.5 Sorensen® 
low rotation burr (Figure 3). The filling out of the bone 
defect was standardized on the right side with 15 mi-
crograms of Genius Gen-phos® SCH in granules, which 
enables ventilation and gas exchange, registered at Anvisa 
#10345500004, and on the left it was not filled out, and it 
served as a control.
Figure 1. Behind-the-ear incision in a rat used in the experiment.
Figure 2. Exposure of the external ear canal and mastoid.
Antibiotic-prophylaxis was used during surgery with 
a dose of cephazolin 0.01 ml/kg. The animals remained 
alone in cages, with controlled lighting and ad libitum 
diet. Post-operative analgesia was done with 2mg/kg sub-
cutaneous ketoprofen BID during 7 days.
Slaughtering
The animals were slaughtered on the 40th day of 
post-op, through the administration of a lethal dose of bar-
biturates, according to what was advocated on Ordinance 
876 from February 15, 2008 by the Federal Board of Vete-
rinary Medicine (CFMV), because at the time of the slau-
ghtering, the animals had a higher weight, around 500g, 
and therefore, neck breaking was no longer the method 
of choice for slaughtering animals with this body weight.
Area morphometry and histological analysis
We then carried out a microscopic analysis, and the 
slides were dyed by hematoxylin-eosin (HE) and evaluated 
by an objective analysis by means of the area morphometry 
(Figure 4), we considered new bone formation and total 
area porosity, in other words, the area which was not 
obliterated by SCH and by new bone formation (Figure 
5). The area morphometry was studied by means of the 
pro-Image Plus v. 4.5 for Windows® software, coupled 
to a Sony video camera and an Olympus BX 50 micros-
cope, calibrated with a 10x magnification lens, using the 
area morphology application through the color difference 
Figure 3. Bone defect creation on the mastoid which will be filled out 
by hydroxyapatite.
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between bone tissue and connective tissue. Through this 
difference in color, the program called Area Morphology 
calculates how much of the total area was filled out by 
hydroxyapatite, and the values were statistically processed 
in comparison to the control group.
There was also no case of Dura-mater perforation during 
surgery, and this would take the animal off the study, 
because the cavity would have its anatomical boundaries 
altered, and the animal would probably die. In relation to 
microscopic analysis, we assessed the presence of a local 
inflammatory process, there was monocyte infiltrates in 
31.44% of the temporal bone grafted with hydroxyapatite 
and in 35.31% of the control group. The neutrophil infil-
tration was present in both groups in minor proportions, 
which characterizes a chronic local inflammatory process. 
This inflammatory process happened to both groups; 
therefore, we stress the fact that it was not higher in the 
hydroxyapatite group, showing that the graft does not 
increase the neutrophil infiltrate, which already happens 
simply because of the normal healing process.
There was no foreign body granuloma formation 
because of the biocompatibility already proven with cal-
cium hydroxyapatite, and also no case of extrusion.
We noticed the presence of bone fragments in 
5.26% of the temporal bones grafted with hydroxyapatite, 
and in 1.13% of the control group, corresponding to the 
new bone formation induced by hydroxyapatite. These 
new bone formation areas may, with time, cause an even 
greater reduction of cavity size, because the osteoblastic 
activity remains for undetermined time.
As far as the area morphometry is concerned, we 
found in the control group (without graft) new bone 
formation in 15.97% and the porosity remained, in other 
words, the area which was not occluded by the graft, in 
84.02% in average; therefore, corresponding to the greater 
part of the area of the bone defect created.
In the hydroxyapatite group, the new bone forma-
tion makes up for an area corresponding to 68.53% of the 
total (p: 0.0022), with porosity persistence around 31.47% 
(Table 1), making the mastoid cavity size reduction with 
hydroxyapatite statistically significant in comparison to 
the control group, when only the mastoid was opened.
Figure 4. Equipment used for area morphometric studies.
Figure 5. Histological analysis of the hydroxyapatite group.
Statistical test utilized
In the histological analysis (percentage of porosity 
of new bone formed) we employed the binomial test, with 
the values given by the software. We fixed at 5% (p< 0.05) 
the null hypothesis rejection level (level of significance), 
in other words, the likelihood of the result being found 
by chance.
RESULTS
Concerning the clinical analysis, all the animals 
remained still and did not have complications in their post-
operative period. No animal had infection nor die during 
the follow up until they were slaughtered on the 40th day. 
Table 1. New bone formation analysis in the area morphometry 
in the control and hydroxyapatite groups.
BONE NEW FORMATION POROSITY GROUP
CONTROL (N=12) 15.97% 84.02%
HYDROXYAPATITE (N=12) 68.53% 31.47%
SIGNIFICANCE P=0.0022
SOURCE: The author (2010)
DISCUSSION
The synthetic calcium hydroxyapatite is approved 
for use with humans by the Food and Drug Administra-
tion (FDA), and it has been used in daily medical practice 
in numerous situations10. It has been showing excellent 
biocompatibility - producing new bone formation, little 
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fibrosis with moderate inflammatory reaction and it does 
not produce a foreign body reaction11.
In 1991, Takahashi described the use of SCH to fill 
up the mastoid12. The results described using hydroxya-
patite associated with a muscle flap in open cavities is 
excellent13. The author reports that hydroxyapatite is safe 
and useful to avoid the problems of mastoid cavities and 
equally to prevent the recurrence of cholesteatomas. Of-
ten times, very large open cavities require an unaesthetic 
extensive meatoplasty and they frequently form granu-
lation tissue and skin shedding which must be cleaned 
frequently so as to avoid reinfection and also to reduce 
the likelihood of cholesteatoma recurrence. Muscle flaps 
alone have a very large resorption and necrosis rate, which 
makes the cavity reduction not very efficient. The use of 
hydroxyapatite alone or in combination with the flaps can 
minimize this problem, because the bone incorporation 
of hydroxyapatite is very good. Another important detail 
is associated with the very porosity of hydroxyapatite, a 
primordial item, being the mastoid a porous bone whi-
ch requires ventilation. Therefore, the bone covered by 
hydroxyapatite is not totally without ventilation, which 
reduces the risk of cholesteatoma formation underneath 
the material used for filling or synthetic material, in this 
case, hydroxyapatite.
Portmann & Portmann14 have already described the 
V/S ratio, in other words, the volume/surface ratio, which 
shows that the larger the epithelized surface of the mastoid 
cavity, the greater must be the air volume penetrating the 
cavity, thus the need for a meatoplasty to enable cavity 
ventilation. On the other hand, there is the possibility of 
keeping this ratio, not only increasing the amount of air 
entering, but also reducing the epithelized surface area, 
reason for starting to use hydroxyapatite.
Bone graft take has 5 stages: 1) inflammatory, pro-
moting a host cell response; 2) tissue revascularization; 
3) osteoconduction, in which the graft has the function 
of being a framework for the growth of vessels and bone 
formation; 4) osteoinduction, the host’s mesenchymal cells 
are induced to turn into osteoblasts by proteins found in 
the graft and 5) bone remodeling with the characteristics 
of continuous bone formation and resorption.
Cholesteatoma recurrence in closed cavities may 
happen in five situations:
1- through the attic defect,
2- through erosion on the bone wall,
3- by pars tensa invagination,
4- by invagination between an attic defect and the 
normal pars tensa,
5- by lamellae of cholesteatomas left in the mastoid 
cavity, especially in the facial nerve recesses and in the 
tympanic sinus. It is for this reason that patients submitted 
to canal-wall-up tympanomastoidectomies, in other words, 
preserving the posterior wall of the external ear canal, must 
be controlled by computerized tomography, and usually 
done after one year of surgery.
Black et al.11 reported the use of a semicircular 
block of hydroxyapatite in the ear attic region in order to 
reduce cholesteatoma recurrence, creating reinforcement 
on the tympanic membrane pars flacida, which reduces 
the possibility of retraction and consequent cholesteatoma 
formation. This surgical step is already routinely done 
with the use of cartilage from the ear pinna or the tragus; 
nonetheless, this cartilage is resorbed with time and this 
enables retraction pocket recurrence.
Kveton et al. reported on the use of hydroxyapatite 
in skull base reconstructions, including surgical accesses 
through the translabyrinthine path, via middle suboccipital 
cranial fossa. Fifteen of their patients were followed up 
during two years and they did not have complications15. 
The goal in these cases is to fill up the cavity created by 
the surgical access, which is usually done with abdominal 
fat, which also has a high rate of resorption16-18.
Matic et al. reported some contraindications concer-
ning the use of hydroxyapatite.19 The main one would be 
doubt about whether or not the cholesteatoma has been 
completely eradicated because of the occlusion of the 
cavity by any autologous graft, or it would create a barrier 
against ventilation and foster cholesteatoma recurrence, 
especially if some microscopic cholesteatoma matrix would 
remain after surgery. In this case, since hydroxyapatite is 
porous, the risk is much smaller than that with a muscle 
flap, which completely blocks mucosa ventilation in this 
cavity, and, therefore, increases the likelihood of disease 
recurrence.
Other authors, such as Hussain et al. confirmed this 
hypothesis and already consider that hydroxyapatite is po-
rous and enables the ventilation of the mucosa underneath 
the graft, even if some epidermal lamellae remain, the 
cholesteatoma would not recur, stressing the gas exchange 
properties of this graft, thus favoring its use.20
In the cholesteatomas which extend to beyond the 
borders of the attic, reaching the antrum or the anterior 
attic region or when associated to important changes to 
the residual mucosa, such as granulation tissue, cholesterol 
granulomas and hyperplasia, it is preferable, according to 
Cruz et al. to perform a canal-wall-down mastoidectomy 
with sound conduction system reconstruction and surgical 
cavity reduction, when needed14. Cavity reduction, with 
occlusion of the mastoid tip and sinodural angle with 
hydroxyapatite reduces the need for post-operative main-
tenance, with a better cosmetic and technical result in the 
meatoplasty. To remove or not to remove the tip of the 
mastoid depends on the final size of this cavity, but it is 
very likely that through the use of hydroxyapatite alone, 
there would be enough reduction, making it unnecessary 
to surgically ablate the mastoid tip.
However, the filling up procedure must be done 
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with hydroxyapatite granules and not the one in the form 
of cement, according to KVETON, because when used, the 
latter fosters post-operative infection. The hydroxyapatite 
cement does not have the technical characteristic of ena-
bling gas exchange such as the granule form.
In the present study we could notice that the caustic 
hydroxyapatite is a biocompatible allograft, which pro-
motes the proper temporal bone fitting. We did not see 
foreign body granuloma formation, congestion or abun-
dant neutrophil infiltration. We only noticed moderate 
monocytes infiltration, characterized by a local moderate 
chronic inflammatory reaction, which also happened to 
the control group, being a normal reaction associated with 
local fibrosis and healing, and not because of the use of an 
allograft - here: hydroxyapatite. We did not have any case 
of graft extrusion, although there are reports of extrusion 
when used to reconstruct the ossicular chain, which is used 
in the form of cement, therefore with less biocompatibility 
and less bone assimilation. Longer studies can be done in 
order to better assess this possible complication.
The microscopic analysis tried to assess the morpho-
logy of the region where the defect was created, observing 
the abundant bone neogenesis in 68.53% of the defects cre-
ated on the bone, therefore showing that a reduction in the 
mastoid cavity size can be reached, according to literature 
data, with the hydroxyapatite graft, statistically significant 
when compared to the control group, opening up a major 
field for ear surgery, especially that of chronic otitis. Thus 
there would be a reduction in the epithelized surface of 
the cavity, which reduces granulation tissue and otorrhea 
arising from insufficient ventilation; therefore, providing 
a more adequate surgical result and greater patient sa-
tisfaction. Moreover, there is less sound scattering; thus, 
bringing about less hearing sequelae caused by surgery. 
Obviously, there are numerous factors associated with the 
degree of hearing loss after surgery, especially ossicular 
chain damage caused by the cholesteatoma-induced bone 
erosion. Moreover, there is less sound scattering; there-
fore, greater vibration stimulus in the new eardrum, with 
lower likelihood of auditory sequelae because of surgery. 
Obviously, there are factors associated with the degree of 
hearing loss after surgery, especially the damage to the 
ossicular chain caused by the cholesteatoma-induced bone 
erosion, because of the release of osteolytic substances 
in the secretion formed when there is an infection in the 
epidermal lamellae. Therefore, the filling up of the mastoid 
cavity with its consequent volumetric reduction cannot, 
in itself, guarantee hearing improvement, there must be 
concurrently an ossicular chain reconstruction, with the 
ossicles themselves, as it is usually done, or through tita-
nium prosthesis available in the market for the different 
degrees of erosion of this ossicular chain. Associating 
ossicular reconstruction with the volumetric reduction 
of the cavity, the auditory result tends to be satisfactory, 
and normal hearing may even be restored in some cases.
With the binomial - statistical test, employed, which is a 
non-parametric test, used when there is only one variable, 
comparing two samples, and with the significance level set 
at 0.05, the result found had a p-value of 0.0022; therefore, 
the likelihood that the observed fact happens when the 
null hypothesis is true, it is much lower than the level 
of significance, making the results presented in terms of 
mastoid cavity size reduction with hydroxyapatite reliable 
and confirmed. The statistical test, through inductive logic, 
confirmed the research’s hypothesis.
Future studies must be carried out for better asses-
sment of these possibilities in human beings, since in the 
literature the number of scientific papers on the topic is 
still small, and the statistically significant results in human 
beings will serve to prove the success of the hydroxyapatite 
use with this goal in mind, since alone the muscle flaps 
did not prove efficient to solve this type of postoperative 
complication, and so far there is no other synthetic material 
with the same properties as hydroxyapatite which can play 
such role in chronic otitis surgery.
Moreover, the fact that the osteoblastic activity ha-
ppened for an undetermined period of time may happen 
beyond bone neogenesis induction, also neo-angiogenesis, 
which would hold possible the increase in osteoblastic acti-
vity with time, making the cavity work with gas exchanges 
and no anatomical sequelae caused by the surgery. This 
can be confirmed with longer prospective studies, with 
the goal of analyzing whether the cavity’s volumetric re-
duction continues to increase with time, and also through 
the microscopic analysis, looking for new vessel formation.
Regardless of all these factors in the long run, 
considering new bone formation and especially neo-
angiogenesis, only the fact that in the short period of time 
of this study, 40 days, there had already been an important 
volumetric reduction of the mastoid cavity with excellent 
allograft take, opens up a major possibility for evolution 
in this type of surgery in regards of immediate and late 
postoperative morbidity, and also a significant reduction 
on the sequelae caused by surgery, chronic otorrhea and 
hearing loss, significantly increasing patient satisfaction, 
not only because of disease cure, but also because of the 
functional results. It is obvious that its use in human beings 
must be carefully analyzed, since this study was carried 
out in healthy animals, with normal and well-ventilated 
mucosa, and also because there are just a handful of stu-
dies confirming its use in human beings, but it still opens 
a major possibility for the future.
CONCLUSIONS
1. We noticed a satisfactory integration of the porous 
hydroxyapatite to the temporal bone in this experimental 
model, with important reduction in the size of the mastoid 
cavity created.
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2. There is bone neogenesis induction with conse-
quent percentage reduction of this cavity. Future studies 
may confirm its potential use in human beings with di-
seased mucosa and little ventilation, opening up a major 
possibility for solving the problem of open cavities with 
chronic otorrhea and hearing loss.
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